{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T07:03:16Z","timestamp":1763622196282,"version":"3.45.0"},"reference-count":38,"publisher":"Begell House","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Oncog"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Nucleolar-spindle-associated protein 1 (&lt;i&gt;NUSAP1&lt;\/i&gt;) participates in the assembly of microtubules and the mitotic spindle. Mitotic spindles are microtubule-based structures that segregate chromosomes during mitosis. Its overexpression and knockdown caused alterations in gene expression programs linked to tumor progression. It was also identified as one of the potential hub genes in various cancers, including the mediation of hepatocellular carcinoma. The present research addresses the &lt;i&gt;NUSAP1&lt;\/i&gt; protein structure refinement and its targeting by the lead molecules identified using various computational approaches. The initial structure of &lt;i&gt;NUSAP1 &lt;\/i&gt;from the Alpha fold database is evaluated using the Ramachandran plot and subjected to multiple energy minimization steps through the YASARA program. The best-optimized structure of &lt;i&gt;NUSAP1&lt;\/i&gt; is obtained and subjected to binding site analysis and virtual screening studies using I-TASSER and Mcule webservers, respectively. From the binding site analysis, His293 was considered the ligand binding site for docking ligands by AutoDock Vina. Selected ligands from the Mcule chemical library were chosen through various filters, and 50 hits were identified for further studies. Among the 50 hits, 27 were identified as non-toxic molecules using a toxicity checker. Further, based on the RO5 violation check, 18 hits exhibited no RO5 violations. Further, for all 18 hits, LigPlot analysis was performed, and 11 hits exhibited hydrogen and hydrophobic interactions with the &lt;i&gt;NUSAP1&lt;\/i&gt; protein. Among 11, three hits showed promising hydrogen and hydrophobic interactions near the potential binding site His293. For the promising three hits with Mcule IDs 9300000909-0-6, 9753624331-0-3, and 1764527053-0-4, ADMET properties were predicted using the PreADMET server. The comparative studies of drug-likeness properties found that all three hits do not violate Lipinski's rule of 5. The comparative studies of ADME properties of three hits found that the 9753624331-0-3 compound exhibits non-inhibiting properties in liver enzymes and p-glycoprotein inhibition. Furthermore, 9753624331-0-3 is computed as the lowest solvation-free energy of -18.1300000 and found to be non-mutagenic, negative for all toxicity studies, including the Ames test, fishes, rats, mice, and daphnia. Based on the drug-likeness, ADME, and toxicity predictions, the 9753624331-0-3 presented favorable properties and hence may be considered the potential lead targeting the &lt;i&gt;NUSAP1&lt;\/i&gt; protein.<\/p>","DOI":"10.1615\/critrevoncog.2025059054","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T12:14:41Z","timestamp":1750076081000},"page":"53-67","source":"Crossref","is-referenced-by-count":0,"title":["Research Article: In Silico Identification of Potential Inhibitors Targeting NUSAP1, A Hub Gene in Hepatocellular Carcinoma"],"prefix":"10.1615","volume":"30","author":[{"given":"Kotta","family":"Dinesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indu Priya","family":"Gudivada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna Chaitanya","family":"Amajala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.","DOI":"10.3322\/caac.21660"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Colagrande S, Inghilesi AL, Aburas S, Taliani GG, Nardi C, Marra F. Challenges of advanced hepatocellular carcinoma. World J Gastroenterol. 2016;22(34):7645-59.","DOI":"10.3748\/wjg.v22.i34.7645"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: Patterns, treatments, and prognosis. Ann Surg. 2015;261(5):947-55.","DOI":"10.1097\/SLA.0000000000000710"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Kim DW, Talati C, Kim R. Hepatocellular carcinoma (HCC): Beyond sorafenib-chemotherapy. J Gastrointest Oncol. 2017;8(2):256-65.","DOI":"10.21037\/jgo.2016.09.07"},{"key":"6","unstructured":"Sell S. AFP as a marker for liver cell injury: Differentiation of tumor growth, hepatotoxicity, and carcinogenesis. UCLA Forum Med Sci. 1978;20:51-8."},{"key":"7","doi-asserted-by":"crossref","unstructured":"Yu J, Park R, Kim R. Promising novel biomarkers for hepatocellular carcinoma: Diagnostic and prognostic insights. J Hepatocell Carcinoma. 2023;10:1105-27.","DOI":"10.2147\/JHC.S341195"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Indu Priya G, Krishna Chaitanya A. Integrative bioinformatics analysis for targeting hub genes in hepatocellular carcinoma treatment. Curr Genomics. 2025;26(1): 48-80.","DOI":"10.2174\/0113892029308243240709073945"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Zheng H, Wang M, Zhang S, Hu D, Yang Q, Chen M, Zhang X, Zhang Y, Dai J, Liou YC. Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response. Int J Biol Sci. 2023;19(14):4689.","DOI":"10.7150\/ijbs.80017"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Meng J, Yang Z, Jiang X, Zou J. Unveiling NUSAP1 as a common gene signature linking chronic HBV infection and HBV-related HCC. Discov Oncol. 2024;15(1):61.","DOI":"10.1007\/s12672-024-00922-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Zeng T, Chen G, Qiao X, Chen H, Sun L, Ma Q, Li N, Wang J, Dai C, Xu F. NUSAP1 could be a potential target for preventing NAFLD progression to liver cancer. Front Pharmacol. 2022;13:823140.","DOI":"10.3389\/fphar.2022.823140"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Li L, Zhou Y, Sun L, Xing G, Tian C, Sun J, Zhang L, He F. NuSAP is degraded by APC\/C-Cdh1 and its overexpression results in mitotic arrest dependent of its microtubules' affinity. Cell Signal. 2007;19(10):2046-55.","DOI":"10.1016\/j.cellsig.2007.05.017"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Xie Q, Ou-Yang W, Zhang M, Wang H, Yue Q. Decreased expression of NUSAP1 predicts poor overall survival in cervical cancer. J Cancer. 2020;11(10):2852-63.","DOI":"10.7150\/jca.34640"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Li M, Yang B. Prognostic value of NUSAP1 and its correlation with immune infiltrates in human breast cancer. Crit Rev Eukaryot Gene Expr. 2022;32(3):45-60.","DOI":"10.1615\/CritRevEukaryotGeneExpr.2021040248"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Qiu J, Xu L, Zeng X, Wu Z, Wang Y, Wang Y, Yang J, Wu H, Xie Y, Liang F, Lv Q. NUSAP1 promotes the metastasis of breast cancer cells via the AMPK\/PPARcy signaling pathway. Ann Transl Med. 2021;9(22):1689.","DOI":"10.21037\/atm-21-5517"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Zhu X, Wu Y, Liao L, Huang W, Yuan L, Huang J, Zhan Y, Liu L. Expression profile and gene regulation network of NUSAP1 in pan cancers based on integrated bioinformatics analysis. Int J Gen Med. 2023;16:4235-48.","DOI":"10.2147\/IJGM.S414270"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, zidek A, Potapenko A, Bridgland A. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583-9.","DOI":"10.1038\/s41586-021-03819-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Ozvoldik K, Stockner T, Krieger E. YASARA model\u00e2\u0080\u0093interactive molecular modeling from two dimensions to virtual realities. J Chem Inform Model. 2023;63(20):6177-82.","DOI":"10.1021\/acs.jcim.3c01136"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Colovos C, Yeates TO. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci. 1993;2(9):1511-9.","DOI":"10.1002\/pro.5560020916"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Bowie JU, L\u00fcthy R, Eisenberg D. A method to identify protein sequences that fold into a known three-dimensional structure. Science. 1991;253(5016):164-70.","DOI":"10.1126\/science.1853201"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Zhou X, Zheng W, Li Y, Pearce R, Zhang C, Bell EW, Zhang G, Zhang Y. I-TASSER-MTD: A deep-learning-based platform for multi-domain protein structure and function prediction. Nat Protoc. 2022;17(10):2326-53.","DOI":"10.1038\/s41596-022-00728-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"MacCarthy EA, Zhang C, Zhang Y, Kc DB. GPU-I-TASSER: A GPU accelerated I-TASSER protein structure prediction tool. Bioinformatics. 2022;38(6):1754-5.","DOI":"10.1093\/bioinformatics\/btab871"},{"key":"23","unstructured":"McCullough J, Fey P, Rahman RJ, Wallace M, Morey S, Sahlberg K, McGonagle E, Hess D, Hatfield C, Sarmiento MR, Velasquez J. Annotating putative D. discoideum proteins using I-TASSER. MicroPubl Biol. 2021;2021:10.17912\/micropub.biology.000420."},{"key":"24","doi-asserted-by":"crossref","unstructured":"Muteeb G, Rehman MT, AlAjmi MF, Aatif M, Farhan M, Shafi S. Identification of a potential inhibitor (MCULE-8777613195-0-12) of New Delhi metallo-B-lactamase-1 (NDM-1) using in silico and in vitro approaches. Molecules. 2022;27(18):5930.","DOI":"10.3390\/molecules27185930"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Odhar HA, Rayshan AM, Ahjel SW, Hashim AA, Albeer A. Molecular docking enabled updated screening of the matrix protein VP40 from Ebola virus with millions of compounds in the MCULE database for potential inhibitors. Bioinformation. 2019;15(9):627-32.","DOI":"10.6026\/97320630015627"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Odhar HA, Hashim AF, Ahjel SW, Humadi SS. Molecular docking and dynamics simulation analysis of the human FXIIa with compounds from the Mcule database. Bioinformation. 2023;19(2):160-6.","DOI":"10.6026\/97320630019160"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Costa MJF, Sette DESPH, Borges BCD. In silico affinity between analgesic\/anti-inflammatory drugs and the transient receptor potential A1 to predict potential pharmacological managing approaches for bleaching sensitivity. An Acad Bras Cienc. 2023;95(Suppl 2):e20230555.","DOI":"10.1590\/0001-3765202320230555"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Laskowski RA, Swindells MB. LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51(10):2778-86.","DOI":"10.1021\/ci200227u"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Nunes AM, de Andrade FD, Filgueiras LA, de Carvalho Maia OA, Cunha RL, Rodezno SV, Maia Filho AL, de Amorim Carvalho FA, Braz DC, Mendes AN. preADMET analysis and clinical aspects of dogs treated with the Organotellurium compound RF07: A possible control for canine visceral leishmaniasis? Environ Toxicol Pharmacol. 2020;80:103470.","DOI":"10.1016\/j.etap.2020.103470"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, Gores G. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018.","DOI":"10.1038\/nrdp.2016.18"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Mohamoud YA, Riome S, Abu-Raddad LJ. Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence. Int J Infect Dis. 2016;46:116-25.","DOI":"10.1016\/j.ijid.2016.03.012"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Ogunwobi OO, Harricharran T, Huaman J, Galuza A, Odumuwagun O, Tan Y, Ma GX, Nguyen MT. Mechanisms of hepatocellular carcinoma progression. World J Gastroenterol. 2019;25(19):2279.","DOI":"10.3748\/wjg.v25.i19.2279"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Yu L, Kong N, Lin Y, Qiu P, Xu Q, Zhang Y, Zhen X, Yan G, Sun H, Mei J, Cao G. NUSAP1 regulates mouse oocyte meiotic maturation. J Cell Biochem. 2023;124(12):1931-47.","DOI":"10.1002\/jcb.30498"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Marsh M, Bron R. SFV infection in CHO cells: Cell-type specific restrictions to productive virus entry at the cell surface. J Cell Sci. 1997;110(Pt 1):95-103.","DOI":"10.1242\/jcs.110.1.95"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Schuster S, Cabrera D, Arrese M, Feldstein AE. Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol. 2018;15(6):349-64.","DOI":"10.1038\/s41575-018-0009-6"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Guo H, Zou J, Zhou L, Zhong M, He Y, Huang S, Chen J, Li J, Xiong J, Fang Z, Xiang X. NUSAP1 promotes gastric cancer tumorigenesis and progression by stabilizing the YAP1 protein. Front Oncol. 2021;10:591698.","DOI":"10.3389\/fonc.2020.591698"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Han Y, Hu X, Yun X, Liu J, Yang J, Tian Z, Zhang X, Zhang Y, Wang X. Nucleolar and spindle associated protein 1 enhances chemoresistance through DNA damage repair pathway in chronic lymphocytic leukemia by binding with RAD51. Cell Death Dis. 2021;12(11):1083.","DOI":"10.1038\/s41419-021-04368-2"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Kotian S, Banerjee T, Lockhart A, Huang K, Catalyurek UV, Parvin JD. NUSAP1 influences the DNA damage response by controlling BRCA1 protein levels. Cancer Biol Ther. 2014;15(5):533-43.","DOI":"10.4161\/cbt.28019"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Gou R, Zheng M, Hu Y, Gao L, Wang S, Liu O, Li X, Zhu L, Liu J, Lin B. Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer. BMC Cancer. 2022;22(1):690.","DOI":"10.1186\/s12885-022-09753-4"}],"container-title":["Critical Reviews\u2122 in Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/22daa3d507b7d8c9\/CRO-59054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:35:45Z","timestamp":1763620545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/439f422d0783386a,40052c1046b3fad2,22daa3d507b7d8c9.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevoncog.2025059054","relation":{},"ISSN":["0893-9675"],"issn-type":[{"type":"print","value":"0893-9675"}],"subject":[],"published":{"date-parts":[[2025]]}}}